Express Scripts Reports Strong Fourth Quarter and Full Year 2010 Results

Express Scripts, Inc. ESRX announced 2010 fourth quarter and full year net income from continuing operations of $329.6 million and $1,204.6 million, or $0.62 and $2.21 per diluted share, respectively. Adjusted earnings per share, as detailed in Table 4 were $0.71 and $2.50 per diluted share for the fourth quarter and full year, respectively. "2010 was a transformational year for Express Scripts," stated George Paz, chief executive officer and chairman. "During the year, we completed the migration of NextRx membership to our systems while continuing to serve existing clients and patients. In the first quarter, we will decommission the NextRx systems and complete the rationalization of our operational footprint. Our strong fourth quarter and full year results demonstrate our ability to successfully execute our business model of alignment that optimizes health outcomes while driving out waste." Fourth Quarter 2010 Review (2010 data reflected on an adjusted basis. See Tables 2 and 3) * Total adjusted claims of 191.3 million, up 24% from 2009 * Gross profit of $833.7 million, up 18% from 2009 * EBITDA of $658.9 million, up 35% from 2009 * EBITDA per adjusted claim of $3.44, up 9% from 2009